$31.21
0.311.00%
In chiusura: -
$31.11
-0.10-0.32%
After hour: Oct 3, 6:17 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Ultragenyx Pharmaceutical. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Ultragenyx Pharmaceutical.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Ultragenyx Pharmaceutical Inc addetti ai lavori?
A Ultragenyx Pharmaceutical Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 2.60K azioni del valore di $80.87K, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno settembre 19, 2025, Alan Theodore Huizenga, l'azienda SVP, CHIEF ACCOUNTING OFFICER sold 64 condivisioni per $29.17 ciascuna.
- Il giorno settembre 8, 2025, Alan Theodore Huizenga, l'azienda SVP, CHIEF ACCOUNTING OFFICER sold 84 condivisioni per $31.39 ciascuna.
- Il giorno settembre 12, 2025, Karah Parschauer, l'azienda EVP AND CHIEF LEGAL OFFICER sold 2.45K condivisioni per $31.17 ciascuna.
Statistiche sulla proprietà per Ultragenyx Pharmaceutical Inc
Numero di azioni emesse
96.372M
Azioni possedute dagli insider
2.055M
Percentuale posseduta dagli Insider
2.17%
Azioni possedute dagli investitori istituzionali
62.383M
Percentuale posseduta dagli investitori istituzionali
64.7%
Sep 19, 2025 | SVP, CHIEF ACCOUNTING OFFICER | -64.00 | $29.17 | -$1.87K | SELL | -0.13% | 50.24K | Sep 18 | ||
Sep 12, 2025 | EVP AND CHIEF LEGAL OFFICER | -2.45K | $31.17 | -$76.37K | SELL | -3.24% | 73.27K | Sep 12 | ||
Sep 08, 2025 | SVP, CHIEF ACCOUNTING OFFICER | -84.00 | $31.39 | -$2.64K | SELL | -0.17% | 50.31K | Sep 05 | ||
Jun 23, 2025 | — | -2.40K | $37.39 | -$89.92K | SELL | -13.55% | 15.34K | Jun 20 | ||
May 05, 2025 | EVP AND CHIEF MEDICAL OFFICER | -762.00 | $37.93 | -$28.90K | SELL | -1.05% | 71.53K | Apr 21 - May 05 | ||
Mar 10, 2025 | CHIEF FINANCIAL OFFICER | -1.78K | $40.40 | -$72.11K | SELL | -1.65% | 106.17K | Mar 06 | ||
Mar 04, 2025 | CBO & EVP | 11.91K | $42.16 | -$275.58K | GRANT | 4.71% | 264.73K | Mar 01 - Mar 03 | ||
Mar 04, 2025 | EVP AND CHIEF LEGAL OFFICER | 5.60K | $42.10 | -$540.82K | GRANT | 8.03% | 75.29K | Mar 01 - Mar 03 | ||
Mar 04, 2025 | EVP AND CHIEF MEDICAL OFFICER | 22.84K | $42.10 | -$376.58K | GRANT | 46.53% | 71.92K | Mar 01 - Mar 03 | ||
Mar 04, 2025 | SEE REMARKS | 18.47K | $42.10 | -$609.21K | GRANT | 20.53% | 108.43K | Mar 01 - Mar 03 | ||
Mar 04, 2025 | PRESIDENT & CEO | 52.13K | $42.20 | -$4.15M | GRANT | 2.47% | 2.16M | Feb 28 - Mar 03 | ||
Mar 04, 2025 | EVP & CHIEF COMMERCIAL OFFICER | 20.15K | $42.10 | -$635.84K | GRANT | 29.77% | 87.86K | Mar 01 - Mar 03 | ||
Mar 04, 2025 | SVP, CHIEF ACCOUNTING OFFICER | 8.28K | $42.20 | -$46.76K | GRANT | 19.80% | 50.12K | Mar 01 - Mar 03 | ||
Mar 03, 2025 | EVP AND CHIEF LEGAL OFFICER | 11.50K | $42.88 | -$128.22K | GRANT | 19.77% | 69.69K | Feb 27 - Mar 01 | ||
Dec 31, 2024 | PRESIDENT & CEO | -11.73K | $42.23 | -$495.23K | SELL | -0.42% | 2.75M | Dec 30 | ||
Dec 11, 2024 | PRESIDENT & CEO | -28.27K | $50.00 | -$413.65K | SELL | -1.01% | 2.76M | Dec 09 - Dec 10 | ||
Oct 11, 2024 | CHIEF FINANCIAL OFFICER | -7.46K | $52.76 | -$393.85K | SELL | -7.48% | 92.30K | Oct 10 | ||
Sep 05, 2024 | PRESIDENT & CEO | -20.00K | $55.85 | -$1.12M | SELL | -0.71% | 2.79M | Sep 03 | ||
Sep 05, 2024 | SVP, CHIEF ACCOUNTING OFFICER | -91.00 | $56.19 | -$5.11K | SELL | -0.22% | 41.55K | Sep 03 | ||
Aug 07, 2024 | PRESIDENT & CEO | -20.00K | $50.17 | -$1.00M | SELL | -0.71% | 2.81M | Aug 06 | ||
Jul 03, 2024 | — | -584.00 | $40.98 | -$23.93K | SELL | -4.64% | 12.01K | Jul 02 | ||
Jun 12, 2024 | EVP AND CHIEF LEGAL OFFICER | -9.81K | $45.00 | -$441.27K | SELL | -14.47% | 57.98K | Jun 12 | ||
Jun 10, 2024 | — | -1.74K | $41.10 | -$71.39K | SELL | -19.33% | 7.25K | Jun 10 | ||
May 03, 2024 | EVP AND CHIEF MEDICAL OFFICER | -354.00 | $43.66 | -$15.46K | SELL | -0.73% | 48.43K | May 02 | ||
Apr 19, 2024 | EVP AND CHIEF MEDICAL OFFICER | -142.00 | $44.10 | -$6.26K | SELL | -0.29% | 48.78K | Apr 18 | ||
Mar 12, 2024 | CBO & EVP | -11.51K | $49.93 | -$574.64K | SELL | -4.35% | 252.82K | Mar 11 | ||
Mar 11, 2024 | — | -12.20K | $50.88 | -$620.44K | SELL | -45.07% | 14.86K | Mar 07 | ||
Mar 05, 2024 | EVP AND CHIEF LEGAL OFFICER | 15.00K | $53.76 | -$201.92K | GRANT | 28.66% | 67.34K | Mar 01 | ||
Mar 05, 2024 | CBO & EVP | 17.47K | $53.75 | -$69.06K | GRANT | 7.08% | 264.33K | Mar 01 | ||
Mar 05, 2024 | SEE REMARKS | 14.52K | $53.76 | -$227.56K | GRANT | 19.43% | 89.27K | Mar 01 | ||
Mar 05, 2024 | SVP, CHIEF ACCOUNTING OFFICER | 13.49K | $53.74 | -$24.83K | GRANT | 48.36% | 41.38K | Mar 01 | ||
Mar 05, 2024 | EVP AND CHIEF MEDICAL OFFICER | 18.16K | $53.76 | -$66.55K | GRANT | 59.03% | 48.93K | Mar 01 | ||
Mar 05, 2024 | EVP & CHIEF COMMERCIAL OFFICER | 15.59K | $53.76 | -$256.33K | GRANT | 30.23% | 67.16K | Mar 01 | ||
Feb 08, 2024 | PRESIDENT & CEO | -30.00K | $45.00 | -$1.35M | SELL | -1.06% | 2.80M | Feb 07 | ||
Jan 02, 2024 | PRESIDENT & CEO | -30.00K | $47.87 | -$1.44M | SELL | -1.05% | 2.83M | Dec 29 | ||
Oct 24, 2023 | CBO & EVP | 0.00 | $19.82 | -$1.03M | SELL-OPTIONS | 0.00% | 246.86K | Oct 23 | ||
Oct 23, 2023 | PRESIDENT & CEO | 0.00 | $20.19 | -$1.28M | SELL-OPTIONS | 0.00% | 2.86M | Oct 19 | ||
Sep 11, 2023 | SVP, CHIEF ACCOUNTING OFFICER | -163.00 | $30.90 | -$46.25K | SELL | -0.69% | 23.61K | Sep 07 | ||
Sep 06, 2023 | EVP & CHIEF COMMERCIAL OFFICER | -6.00K | $37.96 | -$227.76K | SELL | -10.47% | 51.28K | Sep 05 | ||
Sep 06, 2023 | SVP, CHIEF ACCOUNTING OFFICER | -970.00 | $37.15 | -$36.03K | SELL | -3.92% | 23.78K | Sep 01 | ||
Jun 30, 2023 | DIRECTOR | -585.00 | $46.76 | -$27.35K | SELL | -6.11% | 8.98K | Jun 30 | ||
Jun 21, 2023 | EVP & CHIEF COMMERCIAL OFFICER | -305.00 | $48.20 | -$14.70K | SELL | -0.53% | 57.28K | Jun 19 | ||
Jun 09, 2023 | DIRECTOR | 2.38K | $51.65 | -$76.70K | GRANT | 33.01% | 9.57K | Jun 07 - Jun 08 | ||
May 19, 2023 | SEE REMARKS | -2.01K | $50.00 | -$100.60K | SELL | -2.62% | 74.74K | May 18 | ||
May 05, 2023 | EVP AND CHIEF LEGAL OFFICER | -4.38K | $45.00 | -$197.01K | SELL | -7.77% | 51.98K | May 04 | ||
Mar 03, 2023 | EVP AND CHIEF MEDICAL OFFICER | -1.22K | $45.25 | -$175.62K | SELL | -2.54% | 46.72K | Mar 01 | ||
Mar 03, 2023 | EVP AND CHIEF LEGAL OFFICER | 21.50K | $45.25 | -$143.04K | GRANT | 62.08% | 56.14K | Mar 01 | ||
Mar 03, 2023 | CBO & EVP | 19.30K | $45.51 | -$244.03K | ACQUISITION | 8.48% | 246.86K | Mar 01 | ||
Mar 03, 2023 | SVP, CHIEF ACCOUNTING OFFICER | 6.16K | $45.65 | -$65.42K | ACQUISITION | 39.57% | 21.71K | Mar 01 | ||
Mar 03, 2023 | SEE REMARKS | 13.68K | $45.65 | -$501.60K | ACQUISITION | 26.79% | 64.72K | Mar 01 | ||
Mar 03, 2023 | SEE REMARKS | 16.89K | $45.46 | -$353.19K | ACQUISITION | 28.51% | 76.16K | Mar 01 | ||
Mar 03, 2023 | EVP & CHIEF COMMERCIAL OFFICER | 21.00K | $45.25 | -$165.80K | GRANT | 57.78% | 57.34K | Mar 01 | ||
Mar 02, 2023 | SVP, CHIEF ACCOUNTING OFFICER | -639.00 | $43.40 | -$27.73K | SELL | -3.95% | 15.56K | Feb 28 | ||
Jan 03, 2023 | PRESIDENT & CEO | -19.58K | $45.57 | -$892.35K | SELL | -0.69% | 2.82M | Dec 30 | ||
Dec 22, 2022 | SVP, CHIEF ACCOUNTING OFFICER | -2.03K | $43.96 | -$89.28K | SELL | -11.14% | 16.20K | Dec 21 | ||
Oct 17, 2022 | CFO & EXECUTIVE VICE PRESIDENT | -1.63K | $40.16 | -$65.42K | SELL | -2.38% | 66.69K | Oct 14 | ||
Oct 14, 2022 | CFO & EXECUTIVE VICE PRESIDENT | -3.48K | $38.22 | -$133.16K | SELL | -4.85% | 68.32K | Oct 12 | ||
Jun 22, 2022 | EVP & CHIEF COMMERCIAL OFFICER | -295.00 | $54.78 | -$16.16K | SELL | -0.81% | 36.16K | Jun 19 | ||
Apr 19, 2022 | SVP, CHIEF ACCOUNTING OFFICER | -132.00 | $84.55 | -$11.16K | SELL | -0.77% | 16.91K | Apr 16 | ||
Mar 15, 2022 | CBO & EVP | -10.28K | $67.01 | -$688.93K | SELL | -4.32% | 227.56K | Mar 11 | ||
Mar 08, 2022 | EVP AND CHIEF LEGAL OFFICER | -5.14K | $62.95 | -$323.56K | SELL | -12.99% | 34.44K | Mar 07 | ||
Mar 03, 2022 | CFO & EXECUTIVE VICE PRESIDENT | 13.05K | $65.71 | -$62.69K | GRANT | 33.66% | 51.81K | Mar 01 - Mar 03 | ||
Mar 03, 2022 | EVP & CHIEF COMMERCIAL OFFICER | 11.29K | $66.62 | -$180.74K | GRANT | 45.09% | 36.32K | Mar 01 | ||
Mar 03, 2022 | SEE REMARKS | 9.50K | $66.62 | -$299.66K | GRANT | 19.09% | 59.27K | Mar 01 | ||
Mar 03, 2022 | SVP, CHIEF ACCOUNTING OFFICER | 2.87K | $66.62 | -$56.16K | GRANT | 20.22% | 17.05K | Mar 01 | ||
Mar 03, 2022 | SEE REMARKS | 10.77K | $66.62 | -$215.45K | GRANT | 26.73% | 51.04K | Mar 01 | ||
Mar 03, 2022 | EVP AND CHIEF LEGAL OFFICER | 11.11K | $66.62 | -$192.27K | GRANT | 39.05% | 39.58K | Mar 01 | ||
Mar 03, 2022 | CBO & EVP | 11.63K | $66.62 | -$158.16K | GRANT | 5.38% | 227.84K | Mar 01 | ||
Mar 03, 2022 | EVP AND CHIEF MEDICAL OFFICER | 11.18K | $66.62 | -$187.94K | GRANT | 30.41% | 47.94K | Mar 01 | ||
Feb 01, 2022 | EVP AND CHIEF MEDICAL OFFICER | -1.66K | $66.30 | -$109.86K | SELL | -4.31% | 36.76K | Jan 30 | ||
Oct 18, 2021 | EVP AND CHIEF MEDICAL OFFICER | -359.00 | $81.14 | -$29.13K | SELL | -0.93% | 38.42K | Oct 14 | ||
Oct 18, 2021 | EVP & CHIEF COMMERCIAL OFFICER | -303.00 | $81.14 | -$24.59K | SELL | -1.20% | 25.03K | Oct 14 | ||
Oct 18, 2021 | EVP & CHIEF TECH OPS OFFICER | -358.00 | $81.14 | -$29.05K | SELL | -0.88% | 40.15K | Oct 14 | ||
Oct 18, 2021 | SVP, CHIEF ACCOUNTING OFFICER | -959.00 | $81.14 | -$11.36K | SELL | -6.38% | 14.07K | Sep 13 - Oct 14 | ||
Oct 18, 2021 | CBO & EVP | -286.00 | $81.14 | -$23.21K | SELL | -0.13% | 216.27K | Oct 14 | ||
Oct 18, 2021 | EVP AND GENERAL COUNSEL | -310.00 | $81.14 | -$25.15K | SELL | -1.08% | 28.36K | Oct 14 | ||
Oct 18, 2021 | SEE REMARKS | -358.00 | $81.14 | -$29.05K | SELL | -0.71% | 49.76K | Oct 14 | ||
Oct 14, 2021 | CFO & EXECUTIVE VICE PRESIDENT | -6.74K | $82.00 | -$552.52K | SELL | -14.81% | 38.76K | Oct 12 - Oct 14 | ||
Sep 09, 2021 | EVP AND GENERAL COUNSEL | 0.00 | $77.58 | -$338.56K | SELL-OPTIONS | 0.00% | 28.67K | Sep 08 | ||
Sep 02, 2021 | EVP AND CHIEF MEDICAL OFFICER | 0.00 | $77.55 | -$225.53K | SELL-OPTIONS | 0.00% | 38.77K | Sep 01 - Sep 02 | ||
Jul 08, 2021 | EVP & CHIEF COMMERCIAL OFFICER | -375.00 | $91.53 | -$34.32K | SELL | -1.46% | 25.33K | Jul 06 | ||
Jun 23, 2021 | EVP & CHIEF COMMERCIAL OFFICER | -1.01K | $94.82 | -$95.67K | SELL | -3.78% | 25.71K | Jun 19 - Jun 21 | ||
Jun 11, 2021 | EVP AND GENERAL COUNSEL | -1.33K | $100.00 | -$132.90K | SELL | -4.43% | 28.67K | Jun 10 | ||
May 10, 2021 | EVP & CHIEF TECH OPS OFFICER | -363.00 | $113.68 | -$41.27K | SELL | -0.89% | 40.51K | May 06 | ||
May 10, 2021 | EVP AND GENERAL COUNSEL | -313.00 | $113.67 | -$35.58K | SELL | -1.03% | 30.00K | May 06 | ||
May 10, 2021 | SEE REMARKS | -363.00 | $113.69 | -$41.27K | SELL | -0.72% | 50.12K | May 06 | ||
May 10, 2021 | SVP, CHIEF ACCOUNTING OFFICER | -142.00 | $113.67 | -$16.14K | SELL | -0.94% | 15.03K | May 06 | ||
May 10, 2021 | CBO & EVP | -363.00 | $113.69 | -$41.27K | SELL | -0.34% | 106.82K | May 06 | ||
May 10, 2021 | EVP & CHIEF COMMERCIAL OFFICER | -700.00 | $113.67 | -$79.57K | SELL | -2.55% | 26.72K | May 06 - May 07 | ||
May 10, 2021 | EVP AND CHIEF MEDICAL OFFICER | -364.00 | $113.67 | -$41.38K | SELL | -0.93% | 38.77K | May 06 | ||
May 05, 2021 | PRESIDENT & CEO | -30.00K | $107.80 | -$3.23M | SELL | -1.04% | 2.86M | May 03 | ||
Apr 21, 2021 | EVP & CHIEF COMMERCIAL OFFICER | -396.00 | $104.28 | -$41.29K | SELL | -1.42% | 27.42K | Apr 20 | ||
Apr 19, 2021 | EVP AND CHIEF MEDICAL OFFICER | 0.00 | $82.05 | -$270.45K | SELL-OPTIONS | 0.00% | 39.14K | Apr 15 | ||
Mar 09, 2021 | SVP, CONTROLLER AND PAO | -3.00K | $120.69 | -$362.07K | SELL | -18.13% | 13.54K | Mar 08 | ||
Mar 03, 2021 | CBO & EVP | 5.56K | $138.17 | -$631.71K | GRANT | 5.48% | 107.18K | Mar 01 | ||
Mar 03, 2021 | SEE REMARKS | 3.94K | $138.17 | -$856.38K | GRANT | 8.51% | 50.24K | Mar 01 | ||
Mar 03, 2021 | EVP AND GENERAL COUNSEL | 6.17K | $138.17 | -$548.53K | GRANT | 25.63% | 30.23K | Mar 01 | ||
Mar 03, 2021 | SVP, CONTROLLER AND PAO | 828.00 | $138.17 | -$101.14K | GRANT | 5.27% | 16.54K | Mar 01 | ||
Mar 03, 2021 | EVP & CHIEF COMMERCIAL OFFICER | 6.96K | $138.17 | -$438.96K | GRANT | 33.37% | 27.81K | Mar 01 - Mar 02 | ||
Mar 03, 2021 | EVP & CHIEF TECH OPS OFFICER | 5.88K | $138.18 | -$587.96K | GRANT | 16.86% | 40.76K | Mar 01 | ||
Mar 03, 2021 | EVP AND CHIEF MEDICAL OFFICER | 5.59K | $138.18 | -$627.75K | GRANT | 16.67% | 39.14K | Mar 01 | ||
Mar 03, 2021 | PRESIDENT & CEO | -12.89K | $142.04 | -$6.58M | SELL | -0.56% | 2.29M | Mar 01 | ||
Feb 23, 2021 | DIRECTOR | -1.00K | $123.43 | -$383.70K | SELL | -1.31% | 75.16K | Feb 19 - Feb 23 | ||
Feb 03, 2021 | EVP & CHIEF COMMERCIAL OFFICER | -2.52K | $74.69 | -$187.92K | SELL | -10.77% | 20.85K | Jun 03 | ||
Feb 02, 2021 | EVP AND CHIEF MEDICAL OFFICER | -2.24K | $140.36 | -$314.83K | SELL | -6.27% | 33.55K | Jan 30 | ||
Jan 19, 2021 | EVP AND CHIEF MEDICAL OFFICER | 0.00 | $97.09 | -$2.10M | SELL-OPTIONS | 0.00% | 35.79K | Jan 15 | ||
Jan 08, 2021 | SVP, CONTROLLER AND PAO | 0.00 | $80.83 | -$478.60K | SELL-OPTIONS | 0.00% | 15.72K | Jan 07 | ||
Jan 05, 2021 | PRESIDENT & CEO | -30.00K | $136.90 | -$4.11M | SELL | -1.01% | 2.94M | Jan 04 | ||
Nov 04, 2020 | — | -30.00K | $96.82 | -$2.90M | SELL | -1.00% | 2.97M | Nov 02 | ||
Nov 02, 2020 | — | 0.00 | $77.31 | -$451.77K | OPTION EXERCISE | 0.00% | 24.06K | Oct 30 | ||
Oct 30, 2020 | — | 0.00 | $77.25 | -$4.41K | OPTION EXERCISE | 0.00% | 23.97K | Oct 28 | ||
Oct 16, 2020 | — | -262.00 | $88.00 | -$23.06K | SELL | -0.73% | 35.79K | Oct 14 | ||
Oct 16, 2020 | — | -325.00 | $88.00 | -$28.60K | SELL | -1.34% | 23.97K | Oct 14 | ||
Oct 16, 2020 | CBO & EVP | -262.00 | $87.98 | -$23.05K | SELL | -0.26% | 101.48K | Oct 14 | ||
Oct 16, 2020 | — | -220.00 | $88.00 | -$19.36K | SELL | -0.93% | 23.37K | Oct 14 | ||
Oct 16, 2020 | — | -262.00 | $88.00 | -$23.06K | SELL | -0.56% | 46.30K | Oct 14 | ||
Oct 16, 2020 | — | -262.00 | $88.00 | -$23.06K | SELL | -0.75% | 34.70K | Oct 14 | ||
Oct 16, 2020 | — | -146.00 | $87.98 | -$12.85K | SELL | -0.88% | 16.44K | Oct 14 | ||
Oct 16, 2020 | — | -375.00 | $87.99 | -$33.00K | SELL | -0.38% | 97.81K | Oct 14 | ||
Oct 13, 2020 | — | -2.78K | $94.47 | -$262.63K | SELL | -5.63% | 46.56K | Oct 12 | ||
Oct 13, 2020 | — | 0.00 | $74.75 | -$405.00K | OPTION EXERCISE | 0.00% | 24.29K | Oct 08 | ||
Oct 07, 2020 | — | 0.00 | $69.22 | -$415.70K | OPTION EXERCISE | 0.00% | 24.29K | Oct 06 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.